Cardiac Surgery is Associated with Biomarker Evidence of Neuronal Damage
Cardiac surgery is associated with neuronal injury, which is aggravated by extracorporeal circulation.
Transatlantic Editorial: Institutional Investigations of Ethically Flawed Reports in Cardiothoracic Surgery Journals
Whether or not the responsible institution changes or improves its investigational process is up to the institution, of course, but at a minimum the journal will have deployed a potentially effective tool in its efforts to protect the integrity of the cardiothoracic surgery literature.
The Efficacy and Safety of Prophylactic Corticosteroids for the Prevention of Adverse Outcomes in Patients Undergoing Heart Surgery Using Cardiopulmonary Bypass: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
In the present meta-analysis of 62 RCTs (16 457 patients), including the 2 major RCTs (SIRS and DECS trials: 12 001 patients), we found that prophylactic corticosteroids in cardiac surgery did not reduce mortality.
Patient Trends and Outcomes of Surgery for Type A Acute Aortic Dissection in Japan: an Analysis of more than 10 000 Patients from the Japan Cardiovascular Surgery Database
Unadjusted and adjusted operative deaths have shown a decreasing trend, although patients undergoing surgery for acute type A dissection have demonstrated worsening of risk factors, such as age and renal failure.
Japan ECMOnet for COVID-19: Telephone Consultations for Cases with Severe Respiratory Failure Caused by COVID-19
A working group has been formed to provide telephone consultation services for cases with severe respiratory failure caused by COVID-19 in Japan.
Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic
This Viewpoint summarizes key considerations for supporting the health care workforce so health care professionals are equipped to provide care for their patients and communities.
Extracorporeal Membrane Oxygenation – Crucial Considerations during the Coronavirus Crisis
The purpose of this freestanding editorial is to highlight the considerations in ECMO for critically ill patients with this important disease.
Planning and Provision of ECMO Services for Severe ARDS During the COVID-19 Pandemic and Other Outbreaks of Emerging Infectious Diseases
Careful planning, judicious resource allocation, and training of personnel to provide complex therapeutic interventions while adhering to strict infection control measures are all crucial components of an ECMO action plan.
CytoSorbents Devices Wins Emergency Approval to Treat COVID-19 Patients
The Food and Drug Administration says it granted Emergency Use Authorization for CytoSorbent’s (NASDAQ:CTSO) CytoSorb device to treat patients with confirmed Covid-19 admitted to the ICU with confirmed or imminent respiratory failure.
Compassionate Use of Remdesivir for Patients with Severe Covid-19
We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS-CoV-2.
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
We describe a patient with Covid-19 and clinically significant coagulopathy, antiphospholipid antibodies, and multiple infarcts. He was one of three patients with these findings in an intensive care unit designated for patients with Covid-19.
Scavenging Gas Outlet Ports with COVID-19 ECMO and new FDA Recommendations for ECMO
The use of vacuum on the gas outlet port of a membrane oxygenator is a safe practice, if done using vacuum <10 mmHg and tubing with an open leur connector, open wye connector or a cut in the vacuum tubing. It is also advisable to turn the vacuum source off when there is no gas flow through the membrane oxygenator.